DA
ELV icon

Dover Advisors’s Elevance Health ELV Stock Holding History

Dover Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-773
Closed -$250K – 169
2025
Q3 		$250K Hold
773
– – 0.1% 149
2025
Q2 		$301K Sell
773
-2
-0.3% -$804 0.13% 133
2025
Q1 		$337K Hold
775
– – 0.15% 120
2024
Q4 		$286K Hold
775
– – 0.16% 109
2024
Q3 		$403K Sell
775
-22
-3% -$11.8K 0.23% 93
2024
Q2 		$432K Sell
797
-68
-8% -$35.9K 0.27% 89
2024
Q1 		$449K Buy
865
+50
+6% +$24.9K 0.31% 81
2023
Q4 		$384K Hold
815
– – 0.51% 61
2023
Q3 		$355K Hold
815
– – 0.36% 76
2023
Q2 		$362K Sell
815
-50
-6% -$23.1K 0.32% 77
2023
Q1 		$398K Buy
865
+50
+6% +$23.8K 0.38% 70
2022
Q4 		$418K Buy
+815
New +$414K 0.45% 64

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Dover Advisors's ELV Position: Q4 2025 in Review

Dover Advisors sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 773 shares — an estimated $250K sold.

Dover Advisors first reported a position in ELV in Q4 2022 and held it in 12 quarters. The position peaked at $449K in Q1 2024. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Dover Advisors reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Dover Advisors sold 773 Elevance Health shares in Q4 2025, an estimated $250K.
  • Dover Advisors first reported a position in Elevance Health in Q4 2022 and held it in 12 quarters.
  • Dover Advisors's Elevance Health position peaked at $449K in Q1 2024.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Dover Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.